Get the Stockscreener App
0.5997
0.76%
-0.0046
Pre-market:
.61
0.0103
+1.72%
Reviva Pharmaceuticals Holdings Inc stock is traded at $0.5997, with a volume of 3.70M.
It is down -0.76% in the last 24 hours and up +62.70% over the past month.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
See More
Previous Close:
$0.6043
Open:
$0.61
24h Volume:
3.70M
Relative Volume:
0.42
Market Cap:
$41.58M
Revenue:
-
Net Income/Loss:
$-27.11M
P/E Ratio:
-0.9226
EPS:
-0.65
Net Cash Flow:
$-26.55M
1W Performance:
-11.20%
1M Performance:
+62.70%
6M Performance:
-32.62%
1Y Performance:
-46.46%
1-Day Range:
$0.5851
$0.616
1-Week Range:
$0.55
$0.6359
52-Week Range:
$0.2522
$4.28
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Company Profile
Name
Reviva Pharmaceuticals Holdings Inc
Sector
Industry
Phone
(408) 501-8881
Address
10080 N WOLFE ROAD, CUPERTINO
Compare RVPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RVPH
Reviva Pharmaceuticals Holdings Inc
|
0.5997 | 58.22M | 0 | -27.11M | -26.55M | -0.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-29-25 | Initiated | Chardan Capital Markets | Buy |
| Sep-20-23 | Initiated | ROTH MKM | Buy |
| Jun-08-23 | Initiated | The Benchmark Company | Speculative Buy |
| Jan-24-22 | Initiated | H.C. Wainwright | Buy |
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Latest News
What recovery options are there for Reviva Pharmaceuticals Holdings Inc.Swing Trade & Risk Managed Investment Strategies - newser.com
Visual trend scoring systems applied to Reviva Pharmaceuticals Holdings Inc. Equity Warrant2025 Support & Resistance & Verified Short-Term Trading Plans - newser.com
Published on: 2025-11-03 02:08:28 - newser.com
Statistical indicators supporting Reviva Pharmaceuticals Holdings Inc.’s strengthTrade Entry Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Is Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock affected by interest rate hikesJuly 2025 Price Swings & Accurate Intraday Trading Signals - newser.com
Long term hold vs stop loss in Reviva Pharmaceuticals Holdings Inc.July 2025 Opening Moves & Community Driven Trade Alerts - newser.com
Order flow analysis tools used on Reviva Pharmaceuticals Holdings Inc. Equity WarrantJuly 2025 Volume & Consistent Profit Trading Strategies - newser.com
Price action breakdown for Reviva Pharmaceuticals Holdings Inc. Equity WarrantAnalyst Upgrade & Weekly Return Optimization Plans - newser.com
Key resistance and support levels for Reviva Pharmaceuticals Holdings Inc.July 2025 Spike Watch & High Return Trade Opportunity Guides - newser.com
What drives Namura Shipbuilding Co Ltd 8AF stock priceMarket Timing Techniques & Learn What Analysts Rate “Strong Buy” - earlytimes.in
Forecasting Reviva Pharmaceuticals Holdings Inc. Equity Warrant price range with options dataWeekly Investment Recap & Fast Moving Market Watchlists - newser.com
Is it time to cut losses on Reviva Pharmaceuticals Holdings Inc.Quarterly Performance Summary & Technical Pattern Based Signals - newser.com
Intraday pattern recognizer results for Reviva Pharmaceuticals Holdings Inc. Equity WarrantTrade Signal Summary & Expert Approved Momentum Trade Ideas - newser.com
Published on: 2025-11-02 12:27:45 - newser.com
Is Reviva Pharmaceuticals Holdings Inc. stock positioned for digital transformationTrade Entry Summary & Weekly Breakout Stock Alerts - newser.com
Will Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock reach all time highs in 2025Weekly Market Summary & Expert Approved Momentum Ideas - newser.com
Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock chart pattern explainedPortfolio Value Summary & AI Optimized Trading Strategy Guides - newser.com
Is Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock dividend yield sustainable2025 Retail Activity & Verified Entry Point Signals - newser.com
What indicators show strength in Reviva Pharmaceuticals Holdings Inc. Equity WarrantWeekly Stock Recap & Verified Entry Point Signals - newser.com
Applying Elliott Wave Theory to Reviva Pharmaceuticals Holdings Inc. Equity WarrantLong Setup & Stepwise Entry and Exit Trade Signals - newser.com
Historical volatility pattern of Reviva Pharmaceuticals Holdings Inc. visualizedPrice Action & AI Driven Stock Movement Reports - newser.com
How Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock trades before earningsPortfolio Value Report & Free Weekly Watchlist of Top Performers - newser.com
Largest borrow rate increases among liquid names - TipRanks
Why Reviva Pharmaceuticals Holdings Inc. stock is popular among millennialsQuarterly Portfolio Report & Smart Money Movement Alerts - newser.com
Tools to monitor Reviva Pharmaceuticals Holdings Inc. Equity Warrant recovery probabilityPortfolio Risk Report & Weekly High Potential Alerts - newser.com
Published on: 2025-10-31 05:26:09 - newser.com
Published on: 2025-10-31 05:05:57 - newser.com
Can trapped investors hope for a rebound in Reviva Pharmaceuticals Holdings Inc. Equity WarrantJobs Report & Verified Momentum Stock Ideas - newser.com
Risk adjusted return profile for Reviva Pharmaceuticals Holdings Inc. Equity Warrant analyzedTrade Entry Summary & Long Hold Capital Preservation Tips - newser.com
Published on: 2025-10-31 04:07:25 - newser.com
Has Reviva Pharmaceuticals Holdings Inc. found a price floorWeekly Trend Recap & High Return Trade Opportunity Guides - newser.com
Can a trend reversal in Reviva Pharmaceuticals Holdings Inc. lead to recoveryGap Up & Scalable Portfolio Growth Ideas - newser.com
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.62%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):